184 related articles for article (PubMed ID: 8960188)
1. Response to comments on the proposed model of a professional drug label.
Martinez MN; Brown SA; Copeland DD; Haibel GK; Koritz GD; Riddell MG; Riviere JE; Rollins LD
J Am Vet Med Assoc; 1996 Dec; 209(12):2068-70. PubMed ID: 8960188
[No Abstract] [Full Text] [Related]
2. Extra-label rules: the final outcome.
Curry-Galvin E
J Am Vet Med Assoc; 1997 Jan; 210(1):10-2. PubMed ID: 8977639
[No Abstract] [Full Text] [Related]
3. Professional drug labeling.
Terry M
J Am Vet Med Assoc; 1993 May; 202(10):1711-2;discussion 1713-7. PubMed ID: 8514591
[No Abstract] [Full Text] [Related]
4. Helpful tips for extralabel drug use: record keeping, record access, and product labels. The FDA-Center for Veterinary Medicine and the American Veterinary Medicine Association.
J Am Vet Med Assoc; 1998 Mar; 212(5):666-7. PubMed ID: 9556375
[No Abstract] [Full Text] [Related]
5. New FDA rule affects drug labeling.
J Am Vet Med Assoc; 1998 Sep; 213(5):598. PubMed ID: 9731244
[No Abstract] [Full Text] [Related]
6. Extralabel drug use and compounding in veterinary medicine.
Geyer RE
Food Drug Law J; 1997; 52(3):291-5. PubMed ID: 10343027
[No Abstract] [Full Text] [Related]
7. Current FDA policy on use of human-labeled drugs in animals.
Teske RH
J Am Vet Med Assoc; 1993 May; 202(10):1632-3;discussion 1634. PubMed ID: 8514570
[No Abstract] [Full Text] [Related]
8. Responsible extra-label use of drugs.
Cobb DV
J Am Vet Med Assoc; 1996 Nov; 209(9):1545. PubMed ID: 8899012
[No Abstract] [Full Text] [Related]
9. Implications for the FDA/Center for Veterinary Medicine (CVM).
Geyer RE
J Am Vet Med Assoc; 1993 May; 202(10):1718-23. PubMed ID: 8514592
[No Abstract] [Full Text] [Related]
10. Scientific basis for nonapproved use of drugs in veterinary practice.
Brumbaugh GW
J Am Vet Med Assoc; 1993 May; 202(10):1693-6;discussion 1713-7. PubMed ID: 8514586
[No Abstract] [Full Text] [Related]
11. AVMA legislation: partial solution to drug availability problem.
Gloyd JS
J Am Vet Med Assoc; 1993 Apr; 202(7):1055-6. PubMed ID: 8473213
[No Abstract] [Full Text] [Related]
12. Compounding forum: FDA-CVM hears veterinarians' views.
J Am Vet Med Assoc; 1993 Nov; 203(10):1367-72. PubMed ID: 8276690
[No Abstract] [Full Text] [Related]
13. Over-the-counter human drugs; labeling requirements; final rule; technical amendment. Food and Drug Administration, HHS. Final rule; technical amendment.
Fed Regist; 2000 Jan; 65(1):7-9. PubMed ID: 11010625
[TBL] [Abstract][Full Text] [Related]
14. Labeling and manufacturing standards proposed for all dietary supplements.
Horrigan B; Block B
Altern Ther Health Med; 2003; 9(3):22. PubMed ID: 12776471
[No Abstract] [Full Text] [Related]
15. Impact of the Animal Drug Availability Act on veterinary practitioners and the animal health industry.
Troutman LM; Vaughn SD; Schmerfeld G; Beaulieu AJ
J Am Vet Med Assoc; 1997 Jun; 210(11):1597-600. PubMed ID: 9170084
[No Abstract] [Full Text] [Related]
16. An overview of current programs on drug development and regulation for small ruminants--pharmaceutical industry perspective.
Terry M
Vet Hum Toxicol; 1993; 35 Suppl 2():12-3. PubMed ID: 8236759
[No Abstract] [Full Text] [Related]
17. FDA, off-label use, and informed consent: debunking myths and misconceptions.
Beck JM; Azari ED
Food Drug Law J; 1998; 53(1):71-104. PubMed ID: 11795338
[No Abstract] [Full Text] [Related]
18. Proposed NSAID package insert labeling.
Food and Drug Administration U.S. Public Health Service
J Pain Palliat Care Pharmacother; 2006; 20(1):49-55. PubMed ID: 16687359
[TBL] [Abstract][Full Text] [Related]
19. Pros and cons of off-label promotion investigations and prosecutions.
Loucks MK
Food Drug Law J; 2006; 61(3):577-83. PubMed ID: 16989041
[No Abstract] [Full Text] [Related]
20. Antiperspirant drug products for over-the-counter human use; final monograph. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2003 Jun; 68(110):34273-93. PubMed ID: 12795305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
